# Effects of Hyperprolactinemia Induced by Antipsychotic Drugs on Bone Metabolism

> **NCT03675750** · — · UNKNOWN · sponsor: **Shanghai Mental Health Center** · enrollment: 120 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03675750
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-01
- **Primary completion:** 2020-04-30
- **Final completion:** 2020-10-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2019-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03675750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03675750, "Effects of Hyperprolactinemia Induced by Antipsychotic Drugs on Bone Metabolism". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT03675750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*